Suraj Kalia
Stock Analyst at Oppenheimer
(3.58)
# 864
Out of 5,008 analysts
82
Total ratings
44.29%
Success rate
9.23%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Upgrades: Outperform | $60 | $35.24 | +70.26% | 2 | Sep 2, 2025 | |
| PLSE Pulse Biosciences | Initiates: Outperform | $22 | $19.45 | +13.11% | 1 | Jul 7, 2025 | |
| TMDX TransMedics Group | Maintains: Outperform | $130 → $150 | $113.93 | +31.66% | 11 | Jun 17, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $34.73 | +29.57% | 7 | Feb 13, 2025 | |
| VREX Varex Imaging | Maintains: Outperform | $30 → $23 | $11.86 | +93.93% | 6 | Feb 7, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $105 → $120 | $175.75 | -31.72% | 5 | Jan 8, 2025 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $40.75 | -21.47% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $87.49 | +6.30% | 2 | Nov 1, 2024 | |
| ABT Abbott Laboratories | Initiates: Outperform | $130 | $133.74 | -2.80% | 1 | Oct 8, 2024 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $10 | $4.63 | +115.98% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 | $76.56 | +17.55% | 5 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $5.80 | +124.14% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $105.38 | +28.11% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $281.38 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $15.17 | +97.76% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $320 → $200 | $2.50 | +7,900.00% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $76.41 | +26.95% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $26.52 | +5.58% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $2.56 | +75.78% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $2.48 | +545.16% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $449.69 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $660 | $2.33 | +28,226.18% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $76.37 | - | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $4.13 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $23.15 | +331.97% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $66.36 | - | 5 | Sep 12, 2018 |
PROCEPT BioRobotics
Sep 2, 2025
Upgrades: Outperform
Price Target: $60
Current: $35.24
Upside: +70.26%
Pulse Biosciences
Jul 7, 2025
Initiates: Outperform
Price Target: $22
Current: $19.45
Upside: +13.11%
TransMedics Group
Jun 17, 2025
Maintains: Outperform
Price Target: $130 → $150
Current: $113.93
Upside: +31.66%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $34.73
Upside: +29.57%
Varex Imaging
Feb 7, 2025
Maintains: Outperform
Price Target: $30 → $23
Current: $11.86
Upside: +93.93%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $175.75
Upside: -31.72%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $40.75
Upside: -21.47%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $87.49
Upside: +6.30%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $133.74
Upside: -2.80%
TriSalus Life Sciences
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $4.63
Upside: +115.98%
Sep 12, 2024
Maintains: Outperform
Price Target: $90
Current: $76.56
Upside: +17.55%
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $5.80
Upside: +124.14%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $105.38
Upside: +28.11%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $281.38
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $15.17
Upside: +97.76%
Jun 23, 2023
Maintains: Outperform
Price Target: $320 → $200
Current: $2.50
Upside: +7,900.00%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $76.41
Upside: +26.95%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $26.52
Upside: +5.58%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $2.56
Upside: +75.78%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $2.48
Upside: +545.16%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $449.69
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $660
Current: $2.33
Upside: +28,226.18%
Nov 3, 2020
Upgrades: Perform
Price Target: n/a
Current: $76.37
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $4.13
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $23.15
Upside: +331.97%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $66.36
Upside: -